Earnings - 31st March 2009

6:47PM Celgene sees Q1 revs below consensus, reaffirms FY09 EPS and revs below consensus, co expects to achieve FY09 results at the lower end of ranges (CELG)44.40 -0.95 : Co issues downside guidance; co sees Q1 revs of ~$600 mln vs $647.1 mln First Call consensus. Co reaffirms FY09 EPS of $2.05-2.15 vs $2.16 consensus, sees revs of $2.6-2.7 bln vs $2.77 bln consensus. The co expects to achieve results at the lower end of these ranges. CELG is targeting REVLIMID product sales in 2009 to increase to ~$1.7 bln, driven by initiatives to expand its worldwide commercial potential, continued global market share gains and longer treatment durations. The co anticipates that VIDAZA sales will nearly double to ~$400 mln. The co reaffirms its five year outlook as it believes the aggressive global expansion of its hematology and oncology franchise, characterized by multiple product launches in various countries, combined with significant operating leverage, improving gross margins and tax rates, should facilitate top line growth of ~20% and bottom line growth of ~25-30%.

4:11PM Pervasive Sftwr raises Q3 guidance (PVSW) 3.90 +0.16 : Co issues upside guidance for Q3 (Mar), sees EPS of $0.10-0.11 up from $0.05-0.08 vs. $0.07 First Call consensus; sees Q3 (Mar) revs of $12.8-13.1 mln up from $10.5-11.5 vs. $11.14 mln consensus. The co expects to report positive cash flow from operations of approx $2.0 mln in the third quarter of fiscal 2009, ending the quarter with approx $44.0 mln in cash and marketable securities. Pervasive acquired approx 733,000 shares of Pervasive common stock on the open market at a total cost of approx $2.7 mln, or approx $3.72 weighted average price per share, during the quarter ended March 31, 2009. The co has $10 mln authorized repurchase funds remaining under its $10.0 mln stock repurchase program announced in March 2009. Depending on market conditions and other factors, such purchases may be commenced or suspended at any time without prior notice. Issued and outstanding shares of common stock as of March 31, 2009 totaled approx 18.2 mln

4:04PM Apollo Group beats by $0.12, beats on revs (APOL) 78.33 -0.61 : Reports Q2 (Feb) earnings of $0.77 per share, $0.12 better than the First Call consensus of $0.65; revenues rose 26.3% year/year to $876.1 mln vs the $865.5 mln consensus. Co report 20.4% year-over-year increase in University of Phoenix total Degreed Enrollment to 397,700.

11:31AM Alliant Tech acquires Eagle Industries; expects the acquisition to add more than $80 mln to FY10 revenues and slightly accretive to FY10 EPS (ATK) 66.38 +2.38 : Co has acquired Eagle Industries, as it expands its position in the domestic and international tactical accessories markets serving military and law enforcement customers. While terms of the agreement were not disclosed, co expects the acquisition to add more than $80 mln to FY10 revenues, and be slightly accretive to FY10 earnings per share (EPS). Eagle Industries will become part of ATK's Armament Systems group.

Earnings - 8th Jan 08

Thursday, January 08 -

		Before The Open		Actual		First Call	Yr Ago		Yr/Yr Rev
		FCStone	FCSX	-0.11		-0.18	0.45		16.3%
		Great A&P Tea	GAP	-1.35	c	-0.35	-0.29		69.5%
		Helen of Troy	HELE	0.48	c	0.70	0.81		-11.8%
		Matrix Service Co	MTRX	0.38		0.40	0.01		-9.1%
		MSC Industrial	MSM	0.72		0.67	0.70		-1.1%
		RPM Inc	RPM	0.33		0.35	0.43		-1.7%
		Schnitzer Steel	SCHN	-1.21	c	-0.75	0.85		-17.4%
		Shaw Group	SGR	0.75	a	0.66	0.49		11.0%
		Texas Industries	TXI	0.14		0.17	1.05		-17.4%
		After The Close		Actual		First Call	Yr Ago		Yr/Yr Rev
		Allscripts-Misys Healthcare	MDRX	0.14	c	0.13	0.14		4.3%
		Apollo Group	APOL	1.12		0.98	0.83		24.4%
		Demandtec	DMAN	0.05	a	0.03	0.04		19.5%
		Healthways	HWAY	0.37		0.36	0.30		5.5%
		IHS	IHS	0.53		0.52	0.47		16.7%
		Lawson Software	LWSN	0.10	a	0.07	0.09		-5.6%
		Nu Horizons Elec	NUHC	0.01	a	-0.04	0.10		-2.4%
		Synnex	SNX	0.80		0.70	0.61		6.3%

Courtesy - briefing.com 

Earnings - 1st July 2008

4:05PM Apollo Group beats by $0.07, beats on revs (APOL) 46.26 +2.00 : Reports Q3 (May) earnings of $0.85 per share, excluding non-recurring items, $0.07 better than the First Call consensus of $0.78; revenues rose 13.9% year/year to $835.2 mln vs the $806.9 mln consensus. "On June 27, 2008, the Board of Directors authorized an increase of the share repurchase program to an aggregate of $500 mln."

10:00AM CME Group announces Q2 2008 volume averaged 11.1 mln contracts per day, up 7% from year-ago levels; reaffirms op expense guidance (CME) 377.29 -5.70 : Co announces Q2 2008 volume averaged 11.1 mln contracts per day, up 7% from Q2 2007. Quarterly electronic volume increased 16% to 9.1 mln contracts per day, compared with the same quarter last year, and represented 82% of total volume. June volume averaged 12.4 mln contracts per day, up 16% from the prior month, but down 4% from June 2007. Total June volume exceeded 259 mln contracts for the month, of which a record 83% was traded electronically. Total monthly electronic volume increased 4% versus June 2007 to average 10.3 mln contracts per day. Year-to-date 2008 volume through June averaged 12.3 mln contracts per day, up 19% versus the same period last year... Co reiterates that it expects full-year 2008 operating expense to range between $855-870 mln. This guidance includes $18 million of expense over the final three quarters of 2008 -- or ~$6 mln per quarter -- related to the acquisition of Credit Market Analysis Limited at the end of the first quarter. The co expects total Q2 operating expenses to $218-221 mln, which includes costs associated with several strategic initiatives. During the third and fourth quarters of 2008, the co expects to realize merger-related synergies associated with expiration of the e-cbot trading platform contract in mid-July, which will reduce expenses by ~$8 mln per quarter.

7:34AM Schnitzer Steel beats by $0.27, beats on revs (SCHN) 114.60 : Reports Q3 (May) earnings of $2.14 per share, $0.27 better than the First Call consensus of $1.87; revenues rose 37.0% year/year to $972 mln vs the $937.7 mln consensus. Co said that the export markets for ferrous scrap metal continue to strengthen. As a result, based on orders received to date, average ferrous selling prices, net of freight, are expected to increase an additional $100 to $125/ton over the net prices received in the recently completed third quarter. Nonferrous prices are expected to decline slightly. Sales volumes. Fourth quarter ferrous processing sales volumes are expected to increase 175 thousand to 200 thousand tons over the volumes shipped in the third quarter, depending on the timing of shipments. Quarter over quarter nonferrous sales volumes are expected to approximate the record volumes shipped in the third quarter. Margins. Higher export prices for ferrous metals are expected to result in higher margins on both a year over year and quarter over quarter basis.

7:33AM Constellation Brands beats by $0.03, beats on revs; guides FY09 EPS in-line (STZ) 19.86 : Reports Q1 (May) earnings of $0.34 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.31; revenues rose 3.4% year/year to $931.8 mln vs the $906.1 mln consensus. Co issues in-line guidance for FY09, sees EPS of $1.68-1.76, excluding non-recurring items, vs. $1.70 consensus; co sees high single-digit growth in organic net sales, with reported net sales increasing in the mid single-digits yr/yr.